Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (Fed. Cir. 2023) | McDonnell Boehnen Hulbert & Berghoff LLP

In its recent review of a district court decision the Federal Circuit characterized as "a thorough opinion," the Federal Circuit affirmed invalidation for obviousness of four claims...

Related Keywords

,Pfizer Inc ,Teleflex Inc ,Supreme Court ,Teva Pharmaceuticals United States Inc ,Vanda Pharmaceuticals Inc ,District Court ,Intl Co ,Apotex Inc ,Federal Circuit ,Orange Book Listed ,Vanda Pharmaceuticals ,Pharmaceuticals United States ,Defendants Teva ,Hour Sleep Wake ,Hour Sleep Wake Disorder ,Reissue Patent ,Free Running Circadian Rhythms ,Blind Subjects ,Investigational Drugs ,Melatonin Agonist ,Circadian Rhythm Sleep Disorders ,Judge Dyk ,Judges Bryson ,Circuit Judges Dyk ,Circuit Judge ,